Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novartis AG (NYSE:NVS)

78.42
Delayed Data
As of 4:02pm ET
 +0.29 / +0.37%
Today’s Change
69.90
Today|||52-Week Range
106.84
-8.86%
Year-to-Date
The Best Buys in Biopharma Today
9:12am / MotleyFool.com - Paid Partner Content
Drug Stocks Reporting Earnings on May 17: AXON & FWP
May 16 / Zacks.com - Paid Partner Content
Novartis' Cardiovascular Drug Gets Positive Recommendation
May 23 / Zacks.com - Paid Partner Content
Drug Stocks' Earnings Slated for This Week: RDY, AVXS, ESALY
May 11 / Zacks.com - Paid Partner Content
Will These Game-Changing Cancer Treatments Hit the Market in 2016?
May 19 / MotleyFool.com - Paid Partner Content
The Medicines Co. Loss Wider, to Divest Cardiovascular Drugs
May 10 / Zacks.com - Paid Partner Content
Novartis (NVS) to Stop Trial on Breast Cancer Drug Early
May 18 / Zacks.com - Paid Partner Content
Drug Stocks Q1 Earnings Slated on May 11: ACRS, EARS & More
May 10 / Zacks.com - Paid Partner Content
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Ophthotech
May 17 / MotleyFool.com - Paid Partner Content
Teva's (TEVA) Stock Gains on Q1 Earnings & Revenue Beat
May 10 / Zacks.com - Paid Partner Content
Novartis (NVS) Releases Positive Data on Ultibro Breezhaler
May 16 / Zacks.com - Paid Partner Content